Rexulti 3 mg/1
brexpiprazole · TABLET · Otsuka America Pharmaceutical, Inc.
No Recall History
Plain English
Rexulti is a tablet containing brexpiprazole at 3 mg/1, taken oral. Manufactured by Otsuka America Pharmaceutical, Inc..
Key Facts
- Brand Name
- Rexulti
- Generic Name
- brexpiprazole
- NDC Code (Product)
59148-039- Manufacturer
- Otsuka America Pharmaceutical, Inc.
- Strength
- 3 mg/1
- Dosage Form
- TABLET
- Route
- ORAL
- Marketing Status
- Application #
- NDA205422
- Drug Class
- Atypical Antipsychotic [EPC]
- Marketing Start
- 07/10/2015
Recall History
No Recall HistoryFrequently Asked Questions
What is Rexulti used for?
Rexulti contains brexpiprazole. It is a tablet taken oral. Consult your doctor for specific uses.
Is Rexulti a controlled substance?
Rexulti is not classified as a controlled substance by the DEA.
What is the generic name for Rexulti?
The generic name for Rexulti is brexpiprazole. There are 6 other brand versions of brexpiprazole.
What is the NDC code for Rexulti 3 mg/1?
The NDC (National Drug Code) for Rexulti 3 mg/1 is 59148-039, listed by Otsuka America Pharmaceutical, Inc..